State of Wisconsin Investment Board’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-27,437
| Closed | -$2.8M | – | 2610 |
|
|
2023
Q2 | $2.8M | Buy |
27,437
+3,206
| +13% | +$327K | 0.01% | 1194 |
|
|
2023
Q1 | $2.2M | Sell |
24,231
-2,716
| -10% | -$247K | 0.01% | 1264 |
|
|
2022
Q4 | $1.02M | Sell |
26,947
-31,552
| -54% | -$1.2M | ﹤0.01% | 1491 |
|
|
2022
Q3 | $1.47M | Buy |
58,499
+31,247
| +115% | +$785K | ﹤0.01% | 1419 |
|
|
2022
Q2 | $828K | Sell |
27,252
-8,548
| -24% | -$260K | ﹤0.01% | 1770 |
|
|
2022
Q1 | $1.17M | Hold |
35,800
| – | – | ﹤0.01% | 1604 |
|
|
2021
Q4 | $944K | Hold |
35,800
| – | – | ﹤0.01% | 1462 |
|
|
2021
Q3 | $3.6M | Buy |
35,800
+1,100
| +3% | +$111K | 0.01% | 1135 |
|
|
2021
Q2 | $4.91M | Buy |
34,700
+31,339
| +932% | +$4.44M | 0.01% | 1055 |
|
|
2021
Q1 | $335K | Buy |
3,361
+271
| +9% | +$27K | ﹤0.01% | 1771 |
|
|
2020
Q4 | $382K | Sell |
3,090
-130
| -4% | -$16.1K | ﹤0.01% | 1599 |
|
|
2020
Q3 | $314K | Sell |
3,220
-290
| -8% | -$28.3K | ﹤0.01% | 1805 |
|
|
2020
Q2 | $548K | Sell |
3,510
-31,490
| -90% | -$4.92M | ﹤0.01% | 1399 |
|
|
2020
Q1 | $5.05M | Buy |
35,000
+4,900
| +16% | +$707K | 0.02% | 778 |
|
|
2019
Q4 | $6.15M | Hold |
30,100
| – | – | 0.02% | 870 |
|
|
2019
Q3 | $2.42M | Buy |
30,100
+2,700
| +10% | +$217K | 0.01% | 990 |
|
|
2019
Q2 | $2.59M | Buy |
27,400
+2,800
| +11% | +$264K | 0.01% | 976 |
|
|
2019
Q1 | $2.1M | Buy |
24,600
+5,600
| +29% | +$479K | 0.01% | 996 |
|
|
2018
Q4 | $1.07M | Buy |
19,000
+2,800
| +17% | +$157K | ﹤0.01% | 1112 |
|
|
2018
Q3 | $1.33M | Hold |
16,200
| – | – | ﹤0.01% | 1118 |
|
|
2018
Q2 | $567K | Buy |
+16,200
| New | +$567K | ﹤0.01% | 1331 |
|